Healios K.K.

Some 10 years since Japan introduced policies, regulations and review pathways to encourage the development and commercialization of cell therapy products, the country has recently modified some regul

Some 10 years since Japan introduced policies, regulations and review pathways to encourage the development and commercialization of cell therapy products, the country has recently modified some regul

Some 10 years since Japan introduced policies, regulations and review pathways to encourage the development and commercialization of cell therapy products, the country has recently modified some regul

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. ProGen Partners With Rani To Devel